Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some like it hot: curcumin and CFTR.

Pamela B Davis1, Mitchell L Drumm

  • 1Department of Pediatrics, Case Western Reserve University School of Medicine, BRB 8th floor, 2109 Adelbert Road, Cleveland, OH 44106, USA. pamela.davis@case.edu

Trends in Molecular Medicine
|October 7, 2004
PubMed
Summary

Curcumin may restore function to the DeltaF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR), offering a potential treatment for cystic fibrosis (CF). Further research is needed to confirm these findings and their therapeutic implications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-related macular degeneration and dementia: Association through pathogenesis or visual impairment?

Journal of Alzheimer's disease : JAD·2026
Same author

Intestinal adaptations increase basolateral intestinal glucose uptake and glycolysis in a mouse model of cystic fibrosis.

American journal of physiology. Gastrointestinal and liver physiology·2025
Same author

Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States.

Journal of Alzheimer's disease : JAD·2025
Same author

Associations of selective serotonin reuptake inhibitors and long COVID risk in patients with depression: a retrospective cohort study.

Infection·2025
Same author

Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.

Journal of Alzheimer's disease : JAD·2025
Same author

Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study.

Journal of Alzheimer's disease : JAD·2025

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cystic fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene.
  • The DeltaF508 mutation is the most common CFTR allele, leading to protein misfolding and dysfunction.
  • Restoring function to mutant CFTR is a key therapeutic strategy for CF.

Purpose of the Study:

  • To investigate the potential of curcumin, a turmeric-derived compound, to restore function to the DeltaF508 mutant CFTR.
  • To evaluate curcumin's effects in both in vitro systems and in vivo models of CF.

Main Methods:

  • Utilized heterologous expression systems to study CFTR function.
  • Administered curcumin to DeltaF508 CF mice to assess its in vivo efficacy.

Related Experiment Videos

Main Results:

  • Initial studies reported that curcumin restores function to the DeltaF508 mutant CFTR.
  • These findings were observed in both cell-based assays and in animal models.

Conclusions:

  • Curcumin shows promise as a therapeutic agent for cystic fibrosis by potentially correcting DeltaF508 CFTR defects.
  • Despite conflicting results from other labs, the therapeutic potential warrants further comprehensive investigation.